郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster.

期刊：PloS one发表年份：2014作者：Wei Chen; Shiyong Fan; Xinni Xie; Nina Xue; Xueyuan Jin; Lili Wang
阅读更多 →

药效评价SYNTHESIS AND BEHAVIOR OF NUCLEAR PROTEINS DURING THE CELL LIFE CYCLE.

期刊：Journal of cellular and comparative physiology发表年份：1963作者：D M PRESCOTT; M A BENDER
阅读更多 →

药效评价[COMPARATIVE PHARMACOLOGIC STUDY OF TRICHOMONACIDAL PROPERTIES OF SOME NITRATED HETEROCYCLIC MOLECULES].

期刊：Annales pharmaceutiques francaises发表年份：1964作者：R CAVIER; J SAVEL; P BUOT
阅读更多 →

药效评价Modulation of retinotectal transmission by presynaptic 5-HT1B receptors in the superior colliculus of the adult hamster.

期刊：Journal of neurophysiology发表年份：1994作者：R D Mooney; M Y Shi; R W Rhoades
阅读更多 →